Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Evelo Biosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −5 vs. Q4 2022
- Shares held
- 85.7M
- −1.29M (−1.5%) vs. Q4 2022
- Total value
- $15.5M
- −$124.6M (−88.9%) vs. Q4 2022
- New holders
- 5
- 9 more added
- Sold out
- 10
- 10 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $2.63K |
| Q3 2023 | 29 | $52.0M |
| Q2 2023 | 25 | $11.3M |
| Q1 2023 | 39 | $15.5M |
| Q4 2022 | 44 | $140.1M |
| Q3 2022 | 41 | $180.0M |
| Q2 2022 | 46 | $180.4M |
| Q1 2022 | 68 | $161.1M |
| Q4 2021 | 66 | $290.1M |
| Q3 2021 | 64 | $331.6M |
| Q2 2021 | 66 | $645.4M |
| Q1 2021 | 62 | $508.0M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Evelo Biosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 50,427,328 | $9.11M | 0.35% | 00.0% | Unchanged |
| FMR LLC | 16,197,089 | $2.93M | 0.00% | −231,262−1.4% | Reduced |
| State of Michigan Retirement System | 4,070,728 | $735.6K | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 3,625,415 | $655.1K | 0.00% | −52,973−1.4% | Reduced |
| Vanguard Group Inc | 3,168,375 | $572.5K | 0.00% | 00.0% | Unchanged |
| HarbourVest Partners LLC | 3,063,505 | $553.6K | 0.19% | 00.0% | Unchanged |
| BlackRock Inc. | 1,155,394 | $208.8K | 0.00% | −77,287−6.3% | Reduced |
| Alphabet Inc. | 1,060,495 | $190.9K | 0.01% | 00.0% | Unchanged |
| CVI Holdings, LLC | 840,577 | $151.9K | 0.06% | −630,995−42.9% | Reduced |
| Geode Capital Management, LLC | 608,675 | $110.0K | 0.00% | +1,232+0.2% | Added |
| Mayo Clinic | 479,242 | $86.6K | 0.07% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 184,104 | $33.3K | 0.00% | +38,045+26.0% | Added |
| State Street Corp | 152,129 | $27.5K | 0.00% | 00.0% | Unchanged |
| Trustees of Columbia University in the City of New York | 113,850 | $20.6K | 0.04% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 105,300 | $19.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 94,330 | $17.0K | 0.00% | −640−0.7% | Reduced |
| Jefferies Financial Group Inc. | 75,000 | $13.6K | 0.00% | +75,000 | New |
| Millennium Management LLC | 58,418 | $11.0K | 0.00% | −35,423−37.7% | Reduced |
| Morgan Stanley | 58,612 | $10.6K | 0.00% | −20,280−25.7% | Reduced |
| Bank of America Corp | 50,825 | $9.15K | 0.00% | +31,546+163.6% | Added |
| Tower Research Capital LLC (TRC) | 32,327 | $6.00K | 0.00% | +27,007+507.7% | Added |
| Goldman Sachs Group Inc | 25,695 | $4.64K | 0.00% | −5,641−18.0% | Reduced |
| Virtu Financial LLC | 24,337 | $4.00K | 0.00% | +24,337 | New |
| Avantax Planning Partners, Inc. | 15,000 | $2.71K | 0.00% | +15,000 | New |
| Bank of New York Mellon Corp | 13,150 | $2.38K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 10,883 | $1.97K | 0.00% | −11,758−51.9% | Reduced |
| Affinity Capital Advisors, LLC | 10,595 | $1.92K | 0.00% | +10,595 | New |
| UBS Group AG | 7,990 | $1.45K | 0.00% | +3,426+75.1% | Added |
| JPMorgan Chase & Co | 3,927 | $1.00K | 0.00% | +393+11.1% | Added |
| Advisor Group Holdings, Inc. | 1,500 | $326 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1,668 | $301 | 0.00% | +115+7.4% | Added |
| China Universal Asset Management Co., Ltd. | 1,486 | $269 | 0.00% | +373+33.5% | Added |
| Citigroup Inc | 1,249 | $226 | 0.00% | −98,376−98.7% | Reduced |
| Larson Financial Group LLC | 739 | $134 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 402 | $73 | 0.00% | +12+3.1% | Added |
| National Bank of Canada | 100 | $18 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 14 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 156 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,469 | $0 | 0.00% | +1,469 | New |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −90,291−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −61,289−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −52,699−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −52,637−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −31,345−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −29,537−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −18,511−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −10,135−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −9,952−100.0% | Sold out |
| Fairfield Financial Advisors, LTD | 0 | $0 | 0.00% | −1,075−100.0% | Sold out |